Panpan Jiang

1PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 09, 2022
First-line chemotherapy plus immune checkpoint inhibitors or bevacizumab in advanced non-squamous non-small-cell lung cancer without EGFR mutations or ALK fusions.

Panpan Jiang, Luying Geng, Ziyang Mao

Pageof 1

Frequent Collaborators

1 joint publications

Luying Geng

1 joint publications

Yu Yao

1 joint publications

Hui Guo